Description
Chartreusin is an antibiotic compound that also exhibits anticancer activity. Chartreusin binds GC-rich DNA sequences, inhibiting synthesis of RNA and causing free radical accumulation.
Product Unit Size | Cost | Quantity | Stock |
---|
Chartreusin is an antibiotic compound that also exhibits anticancer activity. Chartreusin binds GC-rich DNA sequences, inhibiting synthesis of RNA and causing free radical accumulation.
Cas No. | 6377-18-0 |
---|---|
Purity | ≥98% |
Formula | C32H32O14 |
Formula Wt. | 640.6 |
Chemical Name | Benzo(h)(1)benzopyrano(5,4,3-cde)(1)benzopyran-5,12-dione, 10-((6-deoxy-2-O-(6-deoxy-3-O-methyl-alpha-D- galactopyranosyl)-beta-D-galactopyranosyl)oxy)-6-hydroxy-1- methyl- (9CI) |
Synonym | Lambdamycin, NSC-5159. |
Melting Point | 184-186°C |
Solubility | Soluble in acetone. Practically insoluble in water. |
Appearance | Yellow sold |
Store Temp | -20°C |
---|---|
Ship Temp | Blue Ice |
MSDS | |
---|---|
Info Sheet |
Portugal J. Chartreusin, elsamicin A and related anti-cancer antibiotics. Curr Med Chem Anticancer Agents. 2003 Nov;3(6):411-20. PMID: 14529449.
Uramoto M, Kusano T, Nishio T, et al. Specific binding of chartreusin, an antitumor antibiotic, to DNA. FEBS Lett. 1983 Mar 21;153(2):325-8. PMID: 6311618.
Yagi M, Nishimura T, Suzuki H, et al. Chartreusin, an antitumor glycoside antibiotic, induces DNA strand scission. Biochem Biophys Res Commun. 1981 Feb 12;98(3):642-7. PMID: 7225117.